SM
CALA

Sabby Management’s Calithera Biosciences, Inc CALA Stock Holding History

Sabby Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,440
Closed -$112K – 113
2019
Q2 		$112K Buy
+1,440
New +$163K 0.14% 67
2016
Q4 		– Sell
-16,225
Closed -$1.05M – 344
2016
Q3 		$1.05M Buy
+16,225
New +$1.05M 0.04% 183

Other funds holding CALA

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Sabby Management's CALA Position: Q3 2019 in Review

Sabby Management sold out of Calithera Biosciences, Inc (CALA) in Q3 2019, closing a stake of 1,440 shares — an estimated $112K sold.

Sabby Management first reported a position in CALA in Q3 2016 and held it in 2 quarters. The position peaked at $1.05M in Q3 2016. 85 funds tracked by Wall St. Rank hold CALA as of Q3 2019.

  • Sabby Management reported no remaining Calithera Biosciences, Inc position as of Q3 2019 after selling out during the quarter.
  • Sabby Management sold 1,440 Calithera Biosciences, Inc shares in Q3 2019, an estimated $112K.
  • Sabby Management first reported a position in Calithera Biosciences, Inc in Q3 2016 and held it in 2 quarters.
  • Sabby Management's Calithera Biosciences, Inc position peaked at $1.05M in Q3 2016.
  • 85 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2019.

Based on Sabby Management's 13F filing for Q3 2019, filed 15 Nov 2019.